home news forum careers events suppliers solutions markets expos directories catalogs resources advertise contacts
 
News Page

The news
and
beyond the news
Index of news sources
All Africa Asia/Pacific Europe Latin America Middle East North America
  Topics
  Species
Archives
News archive 1997-2008
 

Wageningen UR’s Prime Diagnostics obtains TGR BioSciences's CaptSure technology licence for use in immunoassay products for the agricultural sector


Wageningen, The Netherlands
October 28, 2015

Prime Diagnostics, a Wageningen UR (University & Research centre) group for the development of high-quality diagnostics, technologies and services for the agricultural sector, has obtained a licence for the use of the CaptSure™ technology of the Adelaide-based biotechnology company, TGR BioSciences. The license agreement will provide non-exclusive access to TGR’s CaptSure™technology for use in  immunoassay products for the agricultural sector.

Under the agreement, TGR will also provide antibody conjugation services, which will allow Wageningen UR to access TGR’s proprietary antibody tagging and immobilisation technology.

In comparison to conventional assays, which usually involve three separate incubations over 2-3 days or more, CaptSure™ technology only requires a single incubation period and can be performed within an hour, without compromising sensitivity or quality.

The simple and robust format of CaptSure™ greatly reduces the costs of labour in medium- and high-throughput screening laboratories and delivers more flexibility for planning of QA/QC operations to the industry. Therefore, CaptSure™ technology is the new gold standard for high-throughput immunoassay technology development around the world.

Mrs. José van Beckhoven, Product Manager Prime Diagnostics at Wageningen UR, said that the patented CaptSure™ technology is a welcome addition to their product line, primarily due to its speed and accuracy. “Our tests, using CaptSure™ immunoassays to find key plant virus targets, have shown the TGR system to be sensitive and fast. We are very pleased to be an early adopter of this technology to bring next-generation products to the potato, horticultural and ornamental industry for virus and bacteria detection.”

Anne Hinton, CEO of TGR BioSciences, said that the license agreement can bring the two organisations closer together and enable further collaboration. “The association of TGR with Wageningen UR’s Prime Diagnostics brings together two groups with complementary expertise,” she said. “We look forward to expanding our relationship with Wageningen UR further, through the combination of our resources”.



More news from:
    . Wageningen University & Research
    . TGR BioSciences Pty Ltd


Website: http://www.wur.nl

Published: October 28, 2015

The news item on this page is copyright by the organization where it originated
Fair use notice


Copyright @ 1992-2024 SeedQuest - All rights reserved